
The objective of the research group is to develop an in vivo continuous monitoring biosensor for the direct detection of small molecule biomarkers in brain tissue of rodent models for elucidating the pharmacodynamic (PD) effect and pharmacokinetic (PK) parameters of drugs against neuropsychiatric diseases. The team will explore the multifaceted task of continuous monitoring biosensor development, including molecular design and assay development, biocompatible sensor architecture, and sensor integration for in vivo monitoring.
Mentors
- Dr. Roberto Arban (Industry mentor)
Director Neuroscience & Mental Health Discovery Research at Boehringer Ingelheim Pharma GmbH & Co. KG., Germany
- Prof. Dr. Heather A. Clark (Academic mentor)
Director, School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, USA
- Dr. Jakub Dostálek (Academic mentor)
Head of Laboratory, Institute of Physics of the Czech Academy of Sciences
Prague, Czech Republic
Publications
- Cátia Santa, Soohyun Park, Artur Gejt, Heather A. Clark, Bastian Hengerer and Khulan Sergelen (2025).
Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor
Analyst
- Soohyun Park, Alice Gerber, Cátia Santa, Gizem Aktug, Bastian Hengerer, Heather A. Clark, Ulrich Jonas, Jakub Dostalek, Khulan Sergelen (2025).
Molecularly Responsive Aptamer-Functionalized Hydrogel for Continuous Plasmonic Biomonitoring
JACS